Haematologica, Vol 92, Issue 2, 287-288 doi:10.3324/haematol.10647
Copyright © 2007 by Ferrata Storti Foundation

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bereczky, Z. Articles by Muszbek, L. Search for Related Content PubMed PubMed Citation Articles by Bereczky, Z. Articles by Muszbek, L.

Thrombosis

Elevated factor XIII level and the risk of myocardial infarction in women

Zsuzsanna Bereczky^*, Emilia Balogh^°, Éva Katona^*, István Czuriga^°, István Édes^°, László Muszbek^*,

^* Clinical Research Center, Thrombosis and Haemostasis Research Group of the Hungarian Academy of Sciences
^° Department of Cardiology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary

Correspondence: László Muszbek MD, PhD, Clinical Research Center, Medical and Health Science Center, University of Debrecen, P.O. Box 40, 4012 Debrecen, Hungary. Fax: international +3652340011. E-mail: muszbek{at}med.unideb.hu

TOP ABSTRACT References

 
Factor XIII (FXIII) activity and antigen levels were determined in 955 patients investigated by coronary angiography. Patients were sub-grouped according to the presence or absence of coronary sclerosis (CS⁺, CS^–) and a positive history of myocardial infarction (MI⁺, MI^–). In females, but not in males, adjusted FXIII activity and antigen levels were significantly elevated in the CS⁺MI⁺ group compared to in the CS⁺MI^– group. FXIII levels in the upper tertile were associated with significantly increased risk of MI in females, but not in males.

Key words: factor XIII, coronary sclerosis, myocardial infarction, women.

Coronary artery disease (CAD) is a major health issue in both women and men, however the time of its onset, the course of the disease the presentation of clinical symptoms and the response to therapy show gender-specific features.^1,2 Fibrinogen and the fibrinolytic inhibitor PAI-1 are the most well-established hemostatic risk factors for CAD and gender-related differences could also be demonstrated concerning the effects of these risk factors. ^3,4 Factor XIII (FXIII) is intimately related to fibrinogen and is a key factor in the regulation of fibrinolysis.⁵ Its active form (FXIIIa) cross-links fibrin - and -chains and covalently attaches ₂-plasmin inhibitor to fibrin. In this way, FXIIIa mechanically stabilizes fibrin and protects it from the fibrinolytic system.

In the present study FXIII activity and antigen levels were measured in a large number of patients with suspected CAD using REA-chrom FXIII and R-ELISA FXIII (Reanal) reagent kits, respectively.^6,7 Nine hundred and fifty-five consecutive patients admitted for coronary angiography were recruited for the study. Patients with 50% stenosis in a major coronary artery or in one of its branches were defined as having coronary sclerosis (CS⁺). The diagnosis of myocardial infarction (MI⁺) was established at the time of its onset according to WHO criteria. At least 3 months were allowed to elapse between the MI and the time of obtaining blood samples for analysis. Patients without significant coronary stenosis and with no history of MI were considered as the clinical control group (CS^–MI^–) to which subgroups of patients with CS and/or MI (CS⁺MI^–, CS^–MI⁺ and CS⁺MI⁺) were compared. Ethical approval was obtained from the University of Debrecen Ethics Committee, and the subjects gave informed consent.

Serum cholesterol, LDL-cholesterol, HDL-cholesterol, triglyceride, apoAI, apoB, lipoprotein (a), homocysteine and fibrinogen were determined by routine laboratory methods. Age, current smoking, body mass index, and the presence of hypertension and diabetes mellitus were recorded. The median age of the women was 57.7 years; 91.7% were menopausal and they were not on hormonal replacement therapy.

Neither FXIII activity nor FXIII antigen levels of the clinical controls differed significantly from those measured in the healthy reference population. Multiple linear regression demonstrated that gender, smoking, cholesterol and fibrinogen levels were independently associated with FXIII activity and FXIII antigen levels, and mean FXIII levels adjusted for these parameters were used in the analysis.

CS and/or MI did not influence adjusted FXIII levels in either the overall population or in the male patients (Table 1). The relationship between CAD and plasma FXIII levels has been investigated in only a few studies including relatively low numbers of males or predominantly male patients.^8–10 The basically negative outcome of these studies agrees well with the results of the present study. The effect of CS or MI on FXIII levels in females has not been addressed previously. CS alone did not have an effect in females, either. However, when CS⁺ females with and without a history of MI were compared, statistically significant elevations of both FXIII activity and antigen levels were observed in the MI⁺ group. The comparison of CS⁺MI⁺ group to clinical controls also revealed a significant elevation of FXIII antigen. Given the small number of patients, the difference between the group with the highest FXIII levels (CS^–MI⁺) and clinical controls did not reach the level of statistical significance.

View this table: [in this window] [in a new window] [Download PPT slide]

Table 1. Adjusted FXIII levels in different groups of male and female patients.*

FXIII levels in the upper tertile (FXIII activity > 110%, FXIII antigen > 24.1 mg/L) did not confer a significant risk of CS to either men or women without a history of MI (CS⁺MI^– versus CS^–MI^–) (Table 2). In contrast to the respective male subgroup, when the female CS⁺MI⁺ subgroup was compared to female clinical controls high odds ratios with high statistical significance were calculated. To separate the effect of elevated FXIII level on the risk of CS and MI even more clearly, subgroups of patients with and without a history of MI, but with significant CS were compared (CS⁺MI⁺ versus CS⁺MI^–). Elevated FXIII levels were associated with a significantly increased risk of MI in women, but not in men.

View this table: [in this window] [in a new window] [Download PPT slide]

Table 2. The effect of FXIII levels in the upper tertile on the risk of coronary sclerosis or myocardial infarction in males and females.

On the basis of these results, elevated FXIII can be regarded as a gender (female)-specific risk factor for MI, and FXIII determination could be a candidate for inclusion in the risk stratification for women. By preventing plasmin-induced degradation of fibrin, elevated FXIII levels could play a role in sustaining newly formed thrombus in coronary arteries. Although it remains to be seen why such a mechanism operates only in women, the results support the view that the clotting system plays a more prominent role in the development of MI in females than in males.

 
Funding: supported by grants from the Hungarian National Research Fund (OTKA T043086), from the Hungarian Academy of Sciences (MTA 11003, 2006TKI227), and from the Hungarian Ministry of Health and Social Affairs (ETT 355/2003, 406/2006).

TOP ABSTRACT References

 

1. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 1999;341:226-32.[Abstract/Free Full Text]
2. Stramba-Badiale M, Fox KM, Priori SG, Collins P, Daly C, Graham I, et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006;27:994-1005.[Abstract/Free Full Text]
3. Vorster HH. Fibrinogen and women’s health. Thromb Res 1999;95:137-54.[CrossRef][Web of Science][Medline]
4. Osse-Gerning N, Wilson IJ, Grant PJ. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb Haemost 1998;79:736-40.[Web of Science][Medline]
5. Muszbek L, Yee V, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999;94:271-304.[CrossRef][Web of Science][Medline]
6. Kárpáti L, Penke B, Katona É, Balogh I, Vámosi G, Muszbek L. A modified optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin Chem 2000;46:1946-55.[Abstract/Free Full Text]
7. Katona É, Haramura G, Kárpáti L, Fachet J, Muszbek L. A simple quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2). Thromb Haemost 2000;83:268-73.[Web of Science][Medline]
8. Kohler HP, Ariens RAS, Mansfield MW, Whitaker P, Grant PJ. Factor XIII activity and antigen levels in patients with coronary artery disease. Thromb Haemost 2001;85:569-70.[Web of Science][Medline]
9. Warner D, Mansfield MW, Grant PJ. Coagulation factor XIII and cardiovascular disease in the UK Asian patients undergoing coronary angiography. Thromb Haemost 2001;85:408-11.[Web of Science][Medline]
10. Chatterjee T, Schröder V, Windecker S, Meier B, Kohler HP. Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease. J Thromb Haemost 2003;1:861-3.[CrossRef][Web of Science][Medline]

This article has been cited by other articles:

				A. H. Shemirani, E. Szomjak, Z. Csiki, E. Katona, Z. Bereczky, and L. Muszbek Elevated factor XIII level and the risk of peripheral artery disease Haematologica, September 1, 2008; 93(9): 1430 - 1432. [Full Text] [PDF]

				P. Medina, S. Navarro, J. Corral, E. Zorio, V. Roldan, A. Estelles, A. Santamaria, F. Marin, J. Rueda, R. M. Bertina, et al. Endothelial protein C receptor polymorphisms and risk of myocardial infarction Haematologica, September 1, 2008; 93(9): 1358 - 1363. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bereczky, Z. Articles by Muszbek, L. Search for Related Content PubMed PubMed Citation Articles by Bereczky, Z. Articles by Muszbek, L.